These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 18258550)
1. Effect of nebivolol and metoprolol treatments on serum asymmetric dimethlyarginine levels in hypertensive patients with type 2 diabetes mellitus. Menevşe E Anadolu Kardiyol Derg; 2008 Feb; 8(1):84; author reply 84. PubMed ID: 18258550 [No Abstract] [Full Text] [Related]
2. Effect of nebivolol and metoprolol treatments on serum asymmetric dimethylarginine levels in hypertensive patients with type 2 diabetes mellitus. Oğuz A; Uzunlulu M; Yorulmaz E; Yalçin Y; Hekim N; Fici F Anadolu Kardiyol Derg; 2007 Dec; 7(4):383-7. PubMed ID: 18065333 [TBL] [Abstract][Full Text] [Related]
3. Nebivolol: a new beta blocker on the horizon. Katira R; Chauhan A Indian Heart J; 2000; 52(1):86-8. PubMed ID: 10820942 [No Abstract] [Full Text] [Related]
4. Does nebivolol improve endothelial dysfunction and will it rescue the reputation of the beta-blockers in the future? Celik T; Iyisoy A Anadolu Kardiyol Derg; 2007 Dec; 7(4):388-9. PubMed ID: 18065334 [No Abstract] [Full Text] [Related]
5. [Clinical and metabolic effects of cardioselective beta-adrenoblockers nebivolol and metoprolol in patients with hypertension and ischemic heart disease associated with type 2 diabetes]. Makolkin VI; Akhmedova OO; Buval'tsev VI; Gavrilov IuV; Petriĭ VV Kardiologiia; 2003; 43(2):40-3. PubMed ID: 12891271 [TBL] [Abstract][Full Text] [Related]
6. Influence of nebivolol and enalapril on metabolic parameters and arterial stiffness in hypertensive type 2 diabetic patients. Kaiser T; Heise T; Nosek L; Eckers U; Sawicki PT J Hypertens; 2006 Jul; 24(7):1397-403. PubMed ID: 16794490 [TBL] [Abstract][Full Text] [Related]
7. [Antiischemic and metabolic effects of nebivolol and metaprolol CR/XL (betalok ZOK) in patients with postinfarction heart dysfunction]. Tepliakov AT; Kuznetsova AV; Stepacheva TA; D'iakova ML; Shilov SN; Bolotskaia LA Klin Med (Mosk); 2005; 83(4):56-9. PubMed ID: 15941146 [TBL] [Abstract][Full Text] [Related]
8. Nebivolol: a new third-generation beta-blocker agent: implications for Clinical Nurse Specialist Practice. O'Malley P Clin Nurse Spec; 2008; 22(3):126-8. PubMed ID: 18438160 [No Abstract] [Full Text] [Related]
9. Loss of arterial and renal nitric oxide bioavailability in hypertensive rats with diabetes: effect of beta-blockers. Mason RP; Kubant R; Jacob RF; Malinski P; Huang X; Louka FR; Borowiec J; Mizuno Y; Malinski T Am J Hypertens; 2009 Nov; 22(11):1160-6. PubMed ID: 19730416 [TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness analysis of nebivolol and metoprolol in essential hypertension: a pharmacoeconomic comparison of antihypertensive efficacy of beta blockers. Patel RS; Sharma KH; Kamath NA; Patel NH; Thakkar AM Indian J Pharmacol; 2014; 46(5):485-9. PubMed ID: 25298575 [TBL] [Abstract][Full Text] [Related]
11. Nebivolol and metoprolol for treating migraine: an advance on beta-blocker treatment? Schellenberg R; Lichtenthal A; Wöhling H; Graf C; Brixius K Headache; 2008 Jan; 48(1):118-25. PubMed ID: 18184294 [TBL] [Abstract][Full Text] [Related]
12. [Pharmacological modulation of NO synthesis in patients with arterial hypertension and endothelial dysfunction]. Buval'tsev VI; Spasskaia MB; Nebieridze DV; Metel'skaia VA; Guseva OI Klin Med (Mosk); 2003; 81(7):51-5. PubMed ID: 12934313 [TBL] [Abstract][Full Text] [Related]
13. Impact of beta-blockers on sleep in patients with mild hypertension: a randomized trial between nebivolol and metoprolol. Yilmaz MB; Erdem A; Yalta K; Turgut OO; Yilmaz A; Tandogan I Adv Ther; 2008 Sep; 25(9):871-83. PubMed ID: 18758699 [TBL] [Abstract][Full Text] [Related]
14. [Administration of cardioselective beta-adrenoblockers in patients with arterial hypertension and/or ischemic heart disease associated with bronchoobstructive syndrome]. Ovcharenko SI; Litvinova IV; Mikolkin VI Ter Arkh; 2007; 79(9):12-8. PubMed ID: 18038580 [TBL] [Abstract][Full Text] [Related]
15. Acute hemodynamic effects of moderate doses of nebivolol versus metoprolol in patients with systolic heart failure. Triposkiadis F; Giamouzis G; Kelepeshis G; Sitafidis G; Skoularigis J; Demopoulos V Int J Clin Pharmacol Ther; 2007 Feb; 45(2):71-7. PubMed ID: 17323786 [TBL] [Abstract][Full Text] [Related]
17. Effects of nebivolol on platelet activation in hypertensive patients: a comparative study with metoprolol. Celik T; Yuksel UC; Iyisoy A; Kursaklioglu H; Ozcan O; Kilic S; Ozmen N; Isik E Int J Cardiol; 2007 Mar; 116(2):206-11. PubMed ID: 16822563 [TBL] [Abstract][Full Text] [Related]
18. Comparative effects of nebivolol and metoprolol on oxidative stress, insulin resistance, plasma adiponectin and soluble P-selectin levels in hypertensive patients. Celik T; Iyisoy A; Kursaklioglu H; Kardesoglu E; Kilic S; Turhan H; Yilmaz MI; Ozcan O; Yaman H; Isik E; Fici F J Hypertens; 2006 Mar; 24(3):591-6. PubMed ID: 16467663 [TBL] [Abstract][Full Text] [Related]
19. Sleep quality in patients with hypertension: additional negative effect of drug therapy. Yontar OC; Erdem A; Yilmaz MB Sleep Med; 2009 Dec; 10(10):1168; author reply 1168-9. PubMed ID: 19467925 [No Abstract] [Full Text] [Related]
20. [Effect of enape combined with nebilet in hypertension]. Gol'drin EN; Samokhina LM Lik Sprava; 2002; (7):104-7. PubMed ID: 12587324 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]